Skip to main content
. 2003 Jan;47(1):138–143. doi: 10.1128/AAC.47.1.138-143.2003

FIG. 3.

FIG. 3.

Passive transcellular diffusion clearance (CLdiff) for different intravenous grepafloxacin dose regimens (15 mg/kg once, 30 mg/kg once, and 50 mg/kg twice). Boxes delimit the interquartile range R (third quartile to first quartile); whiskers indicate 1.5R.